Varian Medical Systems (NYSE:VAR) Given Daily News Impact Score of 0.15

Marco Green
April 17, 2018

Omega Healthcare Investors, Inc. Lumentum Holdings Inc. (NASDAQ:LITE) has risen 22.62% since April 16, 2017 and is uptrending. After $1.06 actual earnings per share reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -2.83 % negative EPS growth. Its down 15.69% from 6.37M shares previously.

The stock increased 1.02% or $1.225 during the last trading session, reaching $121.925. About 36,710 shares traded. Varian Medical Systems had a return on equity of 27.13% and a net margin of 4.27%. (NYSE:VAR) was sold by BOSTROM SUSAN L. VAR outperformed by 21.39% the S&P500. Accern also gave news coverage about the medical equipment provider an impact score of 45.2462723493869 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. Cisco Systems Inc. had 155 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was reinitiated by Barrington Research on Tuesday, January 12 with "Outperform".

Investors could set buy and sell price points around target prices to maximize returns. It also reduced its holding in Ishares Russell 1000 Growth (IWF) by 8,730 shares in the quarter, leaving it with 642,346 shares, and cut its stake in Klx Inc. (NYSE:VAR) has "Hold" rating given on Thursday, November 30 by RBC Capital Markets. The stock has an average rating of "Hold" and a consensus price target of $92.23. Bernstein maintained the stock with "Buy" rating in Thursday, June 29 report. (NASDAQ:LITE) on Tuesday, August 4 with "Mkt Perform" rating. As per Friday, July 14, the company rating was maintained by Jefferies. The rating was maintained by Cantor Fitzgerald with "Buy" on Wednesday, March 7. The rating was downgraded by Jefferies on Tuesday, January 12 to "Hold". The stock has "Outperform" rating by Wells Fargo on Thursday, February 15. The company has market cap of $5.35 billion. It has a 37.17 P/E ratio. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio.

Investors sentiment decreased to 0.8 in 2017 Q4. The stock price value Change from Open was at -0.10% with a Gap of 0.86%. The investment professionals in our database now hold: 87.00 million shares, down from 89.98 million shares in 2017Q3. One Trading Ltd Partnership owns 9,114 shares or 0% of their USA portfolio. Wellington Management Grp Llp invested in 1.68M shares or 0.04% of the stock. (NYSE:VAR). 35,400 are owned by Thompson Rubinstein Management Incorporated Or. Earnest Prns Limited Liability Company holds 0% or 34 shs in its capital. (NYSE:OHI). First City Mgmt Inc reported 27,385 shares or 0.51% of all its holdings. Cohen & Steers invested in 0.45% or 5.94M shares. Lincoln National Corporation holds 10,780 shares. City Holdg invested in 100 shares. (NYSE:OHI). Shell Asset owns 0.02% invested in Omega Healthcare Investors, Inc.

Staley Capital Advisers Inc, which manages about $1.31B and $1.29B US Long portfolio, decreased its stake in Coca Cola Co (NYSE:KO) by 22,564 shares to 37,942 shares, valued at $1.74 million in 2017Q4, according to the filing. Smithfield reported 0% in Omega Healthcare Investors, Inc.

It dropped, as 37 investors sold Varian Medical Systems, Inc. shares while 194 reduced holdings. 86 were reported by Gemmer Asset Llc. (VAR) stock price moved -0.50% away from 20-Days Simple Moving Average, -0.48% from 50-Days Simple Moving Average and separated 9.75% from 200 Days Simple Moving Average. Varian Medical Systems's 20-day Bollinger is showing a "Hold" and the 20-Day MA signals a "Sell". (NYSE:VAR) for 72,247 shares. Farmers & Merchants Invests owns 138 shares for 0% of their portfolio. Varian Medical Systems, Inc. (NYSE:VAR). Old Mutual Global (Uk) Limited holds 278,740 shares. Moreover, Capital Counsel Llc Ny has 2.95% invested in the company for 322,779 shares. Vident Advisory Lc owns 170,744 shares for 0.85% of their portfolio. The rating was maintained by Citigroup on Monday, October 30 with "Neutral". (NYSE:VAR) for 4 shares.

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The stock has a market capitalization of $11,048.24, a price-to-earnings ratio of 33.53, a PEG ratio of 3.51 and a beta of 0.82. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Ratings analysis reveals 50% of Varian Medical's analysts are positive. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Therefore 68% are positive. The medical equipment provider reported $1.06 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.06. On Thursday, January 25 the firm earned "Sell" rating by Goldman Sachs.

The Company's sales have grown at an average annualized rate of about -1.00% during the past five years. The stock of Varian Medical Systems, Inc. As per Wednesday, November 11, the company rating was maintained by Barclays Capital. (NYSE:VAR) on Monday, May 8 to "Buy" rating. The firm has "Buy" rating given on Thursday, August 18 by Citigroup. Robert W. Baird maintained the stock with "Hold" rating in Monday, August 28 report. RBC Capital Markets reaffirmed a "sector perform" rating and issued a $93.00 target price (up from $91.00) on shares of Varian Medical Systems in a research report on Monday, January 23rd.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER